TB
Todd Berard
Chief Marketing Officer

Todd Berard insider trades: Biolife Solutions (BLFS) stock sales

Chief Marketing Officer, Biolife Solutions Last trade Mar 3, 2026 106 Form 4 filings
$35K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
88
Open-market trades
since 2018
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Todd reports to the SEC

Open-market buys and sales

88 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 3, 2026BLFS↓ Sell$7K
Jan 6, 2026BLFS↓ Sell$9K
Dec 9, 2025BLFS↓ Sell$9K
Nov 25, 2025BLFS↓ Sell$9K
Oct 9, 2025BLFS↓ Sell$8K
Sep 11, 2025BLFS↓ Sell$10K
Aug 26, 2025BLFS↓ Sell$9K
Aug 25, 2025BLFS↓ Sell$255K
Jul 7, 2025BLFS↓ Sell$7K
Jun 10, 2025BLFS↓ Sell$9K
May 28, 2025BLFS↓ Sell$8K
Apr 9, 2025BLFS↓ Sell$7K
Apr 1, 2025BLFS↓ Sell$202K
Mar 11, 2025BLFS↓ Sell$39K
Mar 3, 2025BLFS↓ Sell$11K
Feb 12, 2025BLFS↓ Sell$3K
Jan 6, 2025BLFS↓ Sell$9K
Nov 26, 2024BLFS↓ Sell$9K
Nov 12, 2024BLFS↓ Sell10b5-1$2K
Oct 30, 2024BLFS↓ Sell$7K
Sep 16, 2024BLFS↓ Sell$17K
Jun 14, 2024BLFS↓ Sell$202K
May 29, 2024BLFS↓ Sell$8K
May 17, 2024BLFS↓ Sell$2K
May 15, 2024BLFS↓ Sell$227K
Apr 18, 2024BLFS↓ Sell$5K
Apr 15, 2024BLFS↓ Sell$157K
Mar 27, 2024BLFS↓ Sell$9K
Mar 12, 2024BLFS↓ Sell$125K
Feb 21, 2024BLFS↓ Sell$2K
Jan 19, 2024BLFS↓ Sell$21K
Jan 2, 2024BLFS↓ Sell$8K
Dec 1, 2023BLFS↓ Sell$5K
Nov 13, 2023BLFS↓ Sell$1K
Sep 28, 2023BLFS↓ Sell$7K
Aug 25, 2023BLFS↓ Sell$4K
Aug 14, 2023BLFS↓ Sell$2K
Jun 27, 2023BLFS↓ Sell$11K
May 31, 2023BLFS↓ Sell$8K
May 15, 2023BLFS↓ Sell$2K
Apr 6, 2023BLFS↓ Sell$31K
Mar 29, 2023BLFS↓ Sell$11K
Mar 1, 2023BLFS↓ Sell$20K
Feb 9, 2023BLFS↓ Sell$1K
Feb 8, 2023BLFS↓ Sell$251K
Jan 23, 2023BLFS↓ Sell$88K
Jan 18, 2023BLFS↓ Sell$163K
Dec 28, 2022BLFS↓ Sell$8K
Nov 10, 2022BLFS↓ Sell$1K
Sep 29, 2022BLFS↓ Sell$11K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BLFS insiders

Open-market trades in the last 12 months

About Todd Berard's insider trades

Todd Berard is Chief Marketing Officer at Biolife Solutions (BLFS). Since Sep 21, 2018, Todd has reported no open-market purchases and 88 sales worth $9.2M on SEC Form 4. In the last 12 months: 4 sales ($35K).

1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include option exercises (31 filings), grants and awards (14 filings), shares withheld for taxes (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLFS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.